Eledon Pharmaceuticals, Inc.
ELDN· Nasdaq
Released Mar 16, 2020, after the close
10-K filed Mar 17, 2020, 77 days after period end · 0001564590-20-011260
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016 |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | -$4.14M | -$4.57M |
Eledon Pharmaceuticals, Inc. · CIK 1404281 · Engraved from SEC EDGAR
| -$2.11M |
| -$3.74M |
| EPS Diluted | — | — | — | -$0.17 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.